Endocrine Autoimmune Disease as a Fragility of Immune Surveillance against Hypersecreting Mutants.

Hashimoto’s thyroiditis autoimmune disease circuit motif hyperparathyroidism hypersecreting adenoma immune surveillance primary biliary cirrhosis systems biology type 1 diabetes vitiligo

Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
19 05 2020
Historique:
received: 16 12 2019
revised: 14 02 2020
accepted: 27 04 2020
entrez: 21 5 2020
pubmed: 21 5 2020
medline: 18 11 2020
Statut: ppublish

Résumé

Some endocrine organs are frequent targets of autoimmune attack. Here, we addressed the origin of autoimmune disease from the viewpoint of feedback control. Endocrine tissues maintain mass through feedback loops that balance cell proliferation and removal according to hormone-driven regulatory signals. We hypothesized the existence of a dedicated mechanism that detects and removes mutant cells that missense the signal and therefore hyperproliferate and hypersecrete with potential to disrupt organismal homeostasis. In this mechanism, hypersecreting cells are preferentially eliminated by autoreactive T cells at the cost of a fragility to autoimmune disease. The "autoimmune surveillance of hypersecreting mutants" (ASHM) hypothesis predicts the presence of autoreactive T cells in healthy individuals and the nature of self-antigens as peptides from hormone secretion pathway. It explains why some tissues get prevalent autoimmune disease, whereas others do not and instead show prevalent mutant-expansion disease (e.g., hyperparathyroidism). The ASHM hypothesis is testable, and we discuss experimental follow-up.

Identifiants

pubmed: 32433950
pii: S1074-7613(20)30180-1
doi: 10.1016/j.immuni.2020.04.022
pmc: PMC7237888
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

872-884.e5

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Références

Am Fam Physician. 2003 May 1;67(9):1959-66
pubmed: 12751658
Clin Endocrinol (Oxf). 1994 Sep;41(3):359-64
pubmed: 7893282
J Clin Endocrinol Metab. 2002 Sep;87(9):4042-7
pubmed: 12213841
Front Immunol. 2013 Dec 26;4:474
pubmed: 24409179
J Clin Invest. 2012 Jan;122(1):4-12
pubmed: 22214853
Physiol Rev. 2004 Oct;84(4):1155-228
pubmed: 15383650
Immunity. 2013 Nov 14;39(5):846-57
pubmed: 24120362
Eur J Endocrinol. 2002 Jul;147(1):109-16
pubmed: 12088927
Neurosurg Clin N Am. 2003 Jan;14(1):11-23, v
pubmed: 12690976
J Autoimmune Dis. 2005 Mar 11;2(1):1
pubmed: 15762980
PLoS One. 2011 Jan 25;6(1):e16096
pubmed: 21283589
J Urol. 1995 Jun;153(6):1781-4
pubmed: 7752315
Ann N Y Acad Sci. 2003 Jun;994:359-65
pubmed: 12851336
Diabetes. 2002 Dec;51 Suppl 3:S394-404
pubmed: 12475782
Nat Rev Immunol. 2013 Oct;13(10):764-9
pubmed: 23995627
J Immunol. 1994 Mar 1;152(5):2562-8
pubmed: 8133063
Int J Dermatol. 2012 Oct;51(10):1206-12
pubmed: 22458952
Cell Rep. 2019 Dec 17;29(12):3916-3932.e5
pubmed: 31851923
Gut. 1989 May;30(5):573-8
pubmed: 2731749
J Autoimmun. 2009 Aug;33(1):3-11
pubmed: 19349147
Cell Syst. 2017 Feb 22;4(2):231-241.e11
pubmed: 28131824
Sci Rep. 2018 Jul 16;8(1):10694
pubmed: 30013127
Nat Rev Mol Cell Biol. 2007 Oct;8(10):786-97
pubmed: 17878918
Nat Rev Immunol. 2008 Dec;8(12):970-6
pubmed: 19008897
Dev Cell. 2019 Jan 7;48(1):115-125.e4
pubmed: 30503750
Immunity. 2003 Feb;18(2):255-64
pubmed: 12594952
Front Endocrinol (Lausanne). 2016 Nov 07;7:142
pubmed: 27872610
Autoimmun Rev. 2008 Sep;7(8):631-7
pubmed: 18774118
Diabetes. 2016 Apr;65(4):981-95
pubmed: 26740601
Cancer. 2004 Aug 1;101(3):613-9
pubmed: 15274075
Genome Med. 2015 Jun 19;7(1):57
pubmed: 26089985
J Immunol. 1994 Jun 1;152(11):5581-92
pubmed: 7514641
Cold Spring Harb Perspect Med. 2012 Apr;2(4):a007781
pubmed: 22474615
Semin Liver Dis. 2014 Aug;34(3):273-84
pubmed: 25057951
J Invest Dermatol. 2001 Jun;116(6):891-7
pubmed: 11407977
J Clin Invest. 1999 Sep;104(5):527-9
pubmed: 10487765
Biophys J. 2017 Mar 28;112(6):1221-1235
pubmed: 28355549
Am J Pathol. 2011 Feb;178(2):472-84
pubmed: 21281779
Elife. 2019 Apr 05;8:
pubmed: 30947808
Mayo Clin Proc. 1991 Jul;66(7):711-9
pubmed: 1677058
Neuroimmunomodulation. 2009;16(5):265-71
pubmed: 19571587
Clin Case Rep. 2017 Sep 08;5(10):1706-1711
pubmed: 29026577
Autoimmun Rev. 2003 May;2(3):119-25
pubmed: 12848952
Am J Pathol. 1961 Feb;38:227-41
pubmed: 13778683
Lancet. 1998 Sep 26;352(9133):1034
pubmed: 9759751
Diabetes. 2002 Jun;51(6):1842-50
pubmed: 12031972
Ann Intern Med. 1980 Nov;93(5):694-7
pubmed: 7212477
Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):E6630-E6638
pubmed: 27702900
Wien Med Wochenschr. 2016 Oct;166(13-14):424-430
pubmed: 27671008
Nucleic Acids Res. 2020 Jan 8;48(D1):D1057-D1062
pubmed: 31588507
Nat Immunol. 2014 Sep;15(9):815-23
pubmed: 25137456
J Invest Dermatol. 1996 Jul;107(1):63-7
pubmed: 8752841
Endocrinology. 1987 Jan;120(1):381-8
pubmed: 3023033
Sci Transl Med. 2015 May 13;7(287):287ra74
pubmed: 25972006
Front Endocrinol (Lausanne). 2018 Mar 21;9:91
pubmed: 29619006
Immunity. 1997 Jun;6(6):715-26
pubmed: 9208844
Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10365-9
pubmed: 1438221
Proc Natl Acad Sci U S A. 1986 Sep;83(18):6854-7
pubmed: 3018748
Diabetes. 2010 Nov;59(11):2846-53
pubmed: 20699420
Nat Commun. 2017 May 09;8:15183
pubmed: 28485371
Arch Pathol Lab Med. 1983 Sep;107(9):488-91
pubmed: 6309114
Lancet. 2012 Mar 24;379(9821):1155-66
pubmed: 22394559
Nat Immunol. 2008 Mar;9(3):282-91
pubmed: 18204450
Nat Med. 2010 Sep;16(9):1029-34
pubmed: 20693993
J Diabetes Investig. 2012 Feb 20;3(1):52-61
pubmed: 24843546
R Soc Open Sci. 2015 Jul 08;2(7):150016
pubmed: 26587263
Clin Exp Gastroenterol. 2017 Feb 07;10:19-27
pubmed: 28223833
Immunol Today. 2000 Jun;21(6):265-8
pubmed: 10825737
Immunity. 2010 Feb 26;32(2):163-74
pubmed: 20137987
Eur J Endocrinol. 2010 Jun;162(6):1123-9
pubmed: 20299491
Toxicol Pathol. 1995 May-Jun;23(3):606-19
pubmed: 7659963
Arch Dermatol. 1987 Aug;123(8):1053-5
pubmed: 3631983
J Autoimmun. 2009 Nov-Dec;33(3-4):197-207
pubmed: 19819109
Clin Rev Allergy Immunol. 2012 Feb;42(1):102-11
pubmed: 22095454
Immunity. 2015 May 19;42(5):929-41
pubmed: 25992863
Trends Endocrinol Metab. 2014 Aug;25(8):415-24
pubmed: 24751356
Mol Syst Biol. 2016 Nov 8;12(11):886
pubmed: 27875241
Crit Care. 2013 Jun 04;17(3):R106
pubmed: 23734769
Dialogues Clin Neurosci. 2006;8(4):383-95
pubmed: 17290797
Nature. 1990 Jul 12;346(6280):183-7
pubmed: 1694970
Diabetologia. 2011 Mar;54(3):572-82
pubmed: 20936253
J Clin Invest. 2007 Apr;117(4):868-70
pubmed: 17404614
News Physiol Sci. 1998 Aug;13:170-176
pubmed: 11390784
Nat Commun. 2018 Jul 5;9(1):2618
pubmed: 29976994
West J Med. 1974 Nov;121(5):359-65
pubmed: 4617969
J Med Genet. 2009 May;46(5):289-99
pubmed: 19254908
J Autoimmun. 1999 Jun;12(4):259-67
pubmed: 10330297
Annu Rev Immunol. 2012;30:95-114
pubmed: 22149933
Diabetologia. 2011 Sep;54(9):2347-57
pubmed: 21732083
Ann N Y Acad Sci. 1999 Oct 20;885:100-16
pubmed: 10816644
NCHS Data Brief. 2017 Oct;(289):1-8
pubmed: 29155682
J Neuroendocrinol. 1998 Mar;10(3):207-15
pubmed: 9576609
Cell Metab. 2017 Mar 7;25(3):727-738
pubmed: 28190773
Ann Transl Med. 2013 Oct;1(3):29
pubmed: 25332973
Genome Res. 2014 Oct;24(10):1603-12
pubmed: 25024161
Eur J Cell Biol. 2008 Apr;87(4):197-209
pubmed: 18187231
Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):885-90
pubmed: 16418280
J Clin Endocrinol Metab. 2002 Mar;87(3):1010-4
pubmed: 11889153
Arch Biochem Biophys. 2006 Jan 15;445(2):269-77
pubmed: 16098474
J Immunol. 2009 Jul 15;183(2):1166-78
pubmed: 19553539
Trends Immunol. 2016 Feb;37(2):114-125
pubmed: 26795134
Orphanet J Rare Dis. 2012 Jun 18;7:41
pubmed: 22710101
J Mol Endocrinol. 2009 Mar;42(3):191-203
pubmed: 19052254
Physiol Rev. 1992 Jul;72(3):667-97
pubmed: 1320763
Cell Rep. 2015 May 26;11(8):1208-19
pubmed: 26004178
J Physiol. 1999 Jul 15;518 ( Pt 2):315-24
pubmed: 10381581
Diabetologia. 2017 Jun;60(6):1033-1042
pubmed: 28280900
Adv Physiol Educ. 2009 Dec;33(4):270-4
pubmed: 19948673
Oncotarget. 2011 Sep;2(9):684-94
pubmed: 21911918
Nat Genet. 2017 May;49(5):659-665
pubmed: 28369038
J Clin Endocrinol Metab. 2013 Mar;98(3):1122-9
pubmed: 23418315
Neuroscientist. 2014 Jan 6;20(4):343-358
pubmed: 24395337
Orphanet J Rare Dis. 2011 Oct 03;6:63
pubmed: 21967988
Nat Commun. 2017 Nov 27;8(1):1792
pubmed: 29176645
Diabetologia. 2009 Jul;52(7):1369-80
pubmed: 19418039
Bioinformatics. 2017 Sep 15;33(18):2924-2929
pubmed: 28481982
Diagn Pathol. 2011 Aug 26;6:80
pubmed: 21871063
Clin Endocrinol (Oxf). 2010 Jul;73(1):18-21
pubmed: 20039888
Mol Cell Endocrinol. 2003 Dec 31;213(1):31-45
pubmed: 15062572
Cold Spring Harb Perspect Biol. 2012 Jun 01;4(6):
pubmed: 22661634
J Am Acad Dermatol. 1983 Nov;9(5):689-96
pubmed: 6643767
Nature. 2015 Dec 10;528(7581):225-30
pubmed: 26605524
Cell Metab. 2019 May 7;29(5):1045-1060.e10
pubmed: 30799288
J Thyroid Res. 2012;2012:351864
pubmed: 23365787
Sci Immunol. 2018 Feb 2;3(20):
pubmed: 29429978
J Cell Sci. 2006 Oct 15;119(Pt 20):4199-206
pubmed: 16984975
Trends Endocrinol Metab. 2016 Jun;27(6):353-362
pubmed: 27094501
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S226-37
pubmed: 20176260
Trends Immunol. 2001 Aug;22(8):443-9
pubmed: 11473834
Am Fam Physician. 2013 Mar 1;87(5):337-46
pubmed: 23547550
J Immunol. 2011 Mar 15;186(6):3787-97
pubmed: 21325620
Kidney Int. 2000 Nov;58(5):1980-6
pubmed: 11044218
Mol Syst Biol. 2017 Jun 26;13(6):933
pubmed: 28652282
Nat Med. 2017 Apr;23(4):501-507
pubmed: 28263308
Immunity. 2016 Feb 16;44(2):233-45
pubmed: 26872694
Curr Opin Immunol. 2013 Dec;25(6):676-82
pubmed: 24238922
J Bone Miner Res. 2002 Nov;17 Suppl 2:N18-23
pubmed: 12412773
N Engl J Med. 1998 Jan 22;338(4):226-30
pubmed: 9435328
J Invest Dermatol. 1995 Nov;105(5):655-9
pubmed: 7594638
Eur J Immunol. 2002 Nov;32(11):3181-90
pubmed: 12555663
J Clin Endocrinol Metab. 1992 Mar;74(3):645-53
pubmed: 1740500
Chemistry. 2018 Jan 2;24(1):47-55
pubmed: 29052256

Auteurs

Yael Korem Kohanim (Y)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel.

Avichai Tendler (A)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel.

Avi Mayo (A)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel.

Nir Friedman (N)

Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.

Uri Alon (U)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel. Electronic address: uri.alon@weizmann.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH